## Abstract An erratum for this article appears in the January, 2004 issue of __Movement__ Disorders (Mov Disord 2004;19:119). Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SN
Clarification: Pathogenic role of glial cells in Parkinson's disease
β Scribed by Serge Przedborski
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 26 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The original article to which this Clarification refers was published in the February 2003 issue of Movement Disorders (Teismann P, Tieu K, Cohen O, Choi DK, Wu dC, Marks D, Vila M, JacksonβLewis V, Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov Disord 2003;18:121β129.). Β© 2003 Movement Disorder Society
π SIMILAR VOLUMES
Hippocampal atrophy and neuron loss are early and reproducible findings in Alzheimer's disease, and recent magnetic resonance imaging studies indicate that hippocampal atrophy may also be present in Parkinson's disease (PD). To determine whether or not cell loss occurs in PD, we estimated the total
Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects approximately 1,000,000 Americans. The cause of the disease remains unknown. The histopathological hallmarks of the disease are dopaminergic striatal insufficiency secondary to a loss of dopaminergic neurons in the sub
## Abstract Despite intense efforts at the bench and at the bedside, few therapeutic strategies exist to combat the consequences of cerebral ischemia. Traditionally, a βneurocentricβ view has dominated research in this field. Evidence is now accumulating that glial cells, in particular astrocytes,